Xenon Pharmaceuticals (XENE) PT Lowered to $49 at Wedbush
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Price: $58.65 -0.26%
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Xenon Pharmaceuticals (NASDAQ: XENE) to $49.00 (from $50.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Ametek Inc. (AME) PT Raised to $290 at BNP Paribas Exane
- Destination XL Group (DXLG) PT Lowered to $1.25 at DA Davidson on Weak Consumer Spending
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
